Ovid Therapeutics Inc. (OVID) Tops Q2 EPS by 2c

Ovid Therapeutics Inc. (NASDAQ: OVID) reported Q2 EPS of ($0.18), $0.02 better than the analyst estimate of ($0.20).

For earnings history and earnings-related data on Ovid Therapeutics Inc. (OVID) click here.

You May Also Be Interested In

• Ovid Therapeutics Inc (OVID) PT Raised to $5 at H.C. Wainwright
• DA Davidson Reiterates Buy Rating on Oracle (ORCL) Following Q1 Print
• Premarket movers: Oracle surges on AI growth, ACV auctions jumps on $1.9B deal